HNRNPA2B1-mediated m6A modification of lncRNA MEG3 promotes tumorigenesis and metastasis of NSCLC by regulating miR-21-5p/PTEN axis and may offer a new epigenetic regulatory mechanism and a potential therapeutic target for NSCLC. Here, MEG3 is linked to non-small cell lung carcinoma.